NPY4R
Basic information
Region (hg38): 10:46461099-46465958
Previous symbols: [ "PPYR1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPY4R gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 5 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 5 | |||||
Total | 0 | 0 | 3 | 0 | 9 |
Variants in NPY4R
This is a list of pathogenic ClinVar variants found in the NPY4R region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-46461589-T-T | Benign (May 14, 2018) | |||
10-46461612-G-T | not specified | Uncertain significance (May 01, 2024) | ||
10-46461654-T-A | not specified | Uncertain significance (Nov 09, 2021) | ||
10-46461688-A-A | Benign (May 14, 2018) | |||
10-46461700-C-T | not specified | Uncertain significance (Oct 04, 2024) | ||
10-46461739-A-A | Benign (May 14, 2018) | |||
10-46461746-A-G | not specified | Uncertain significance (Aug 13, 2021) | ||
10-46461765-G-C | not specified | Uncertain significance (Aug 12, 2024) | ||
10-46461812-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
10-46461918-A-G | Benign (May 14, 2018) | |||
10-46461918-A-A | Benign (May 14, 2018) | |||
10-46461945-A-A | Benign (May 14, 2018) | |||
10-46462052-A-C | not specified | Uncertain significance (Jun 02, 2024) | ||
10-46462166-T-C | not specified | Uncertain significance (Dec 10, 2024) | ||
10-46462251-T-C | not specified | Uncertain significance (May 30, 2023) | ||
10-46462271-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
10-46462341-C-A | Benign (May 14, 2018) | |||
10-46462402-C-G | Benign (Aug 15, 2017) | |||
10-46462504-G-A | Benign (May 08, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPY4R | protein_coding | protein_coding | ENST00000374312 | 1 | 4787 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.21e-7 | 0.173 | 125697 | 0 | 49 | 125746 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.139 | 164 | 169 | 0.970 | 0.00000897 | 2243 |
Missense in Polyphen | 49 | 59.307 | 0.82621 | 833 | ||
Synonymous | -1.80 | 94 | 74.3 | 1.27 | 0.00000436 | 691 |
Loss of Function | -0.172 | 9 | 8.46 | 1.06 | 4.60e-7 | 95 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000707 | 0.000707 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000193 | 0.000193 |
Middle Eastern | 0.000707 | 0.000707 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is PP, PP (2-36) and [Ile-31, Gln-34] PP > [Pro-34] PYY > PYY and [Leu-31, Pro-34] NPY > NPY > PYY (3-36) and NPY (2-36) > PP (13- 36) > PP (31-36) > NPY free acid.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);regulation of eif2;akap95 role in mitosis and chromosome dynamics;GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- rvis_EVS
- 1.07
- rvis_percentile_EVS
- 91.68
Haploinsufficiency Scores
- pHI
- 0.124
- hipred
- N
- hipred_score
- 0.219
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npy4r
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding